Read + Share
Kageyama T, Tanaka S, Etori K, Hattori K, et al. Immunological features that associate with the strength of antibody responses to
BNT162b2 mRNA vaccine against SARS-CoV-2. Vaccine 2022 Feb 25. pii: S0264-410X(22)00192.
PMID: 35241300
|
 |
|
Kageyama T, Tanaka S, Etori K, Hattori K, et al. Immunological features that associate with the strength of antibody responses to
BNT162b2 mRNA vaccine against SARS-CoV-2. Vaccine 2022 Feb 25. pii: S0264-410X(22)00192.
PMID: 35241300
|
|
|
|